Corteva (CTVA) – Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Corteva (NYSE: CTVA) in the last few weeks:

• 2/20/2026 – Corteva was downgraded by Zacks Research from “strong-buy” to “hold”.
• 2/17/2026 – Corteva had its price target raised by Mizuho from $80.00 to $82.00. They now have an “outperform” rating on the stock.
• 2/11/2026 – Corteva had its price target raised by CICC Research from $70.00 to $80.00. They now have an “outperform” rating on the stock.
• 2/9/2026 – Corteva was downgraded by UBS Group AG from “buy” to “hold”.
• 2/9/2026 – Corteva was given a new $80.00 price target by UBS Group AG. They now have a “neutral” rating on the stock.
• 2/7/2026 – Corteva was downgraded by Wall Street Zen from “buy” to “hold”.
• 2/5/2026 – Corteva was given a new $86.00 price target by Oppenheimer Holdings, Inc..
• 2/5/2026 – Corteva had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $88.00 price target on the stock.
• 2/5/2026 – Corteva had its price target raised by Wells Fargo & Company from $77.00 to $85.00. They now have an “overweight” rating on the stock.
• 2/5/2026 – Corteva had its price target raised by Citigroup Inc. from $74.00 to $80.00. They now have a “neutral” rating on the stock.
• 2/5/2026 – Corteva had its price target raised by Wolfe Research from $81.00 to $86.00. They now have an “outperform” rating on the stock.
• 2/5/2026 – Corteva had its price target raised by Deutsche Bank Aktiengesellschaft from $85.00 to $90.00. They now have a “buy” rating on the stock.
• 2/5/2026 – Corteva had its price target raised by Royal Bank Of Canada from $80.00 to $89.00. They now have an “outperform” rating on the stock.
• 2/5/2026 – Corteva was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have a $77.00 price target on the stock, up from $75.00.
• 1/27/2026 – Corteva had its price target raised by Oppenheimer Holdings, Inc. from $76.00 to $78.00. They now have an “outperform” rating on the stock.
• 1/22/2026 – Corteva was upgraded by Zacks Research from “hold” to “strong-buy”.
• 1/21/2026 – Corteva had its price target raised by JPMorgan Chase & Co. from $70.00 to $75.00. They now have an “overweight” rating on the stock.
• 1/21/2026 – Corteva had its price target raised by Citigroup Inc. from $70.00 to $74.00. They now have a “neutral” rating on the stock.
• 1/17/2026 – Corteva was upgraded by Wall Street Zen from “hold” to “buy”.
• 1/16/2026 – Corteva was upgraded by Argus to “strong-buy”.
• 1/16/2026 – Corteva had its price target raised by Wolfe Research from $80.00 to $81.00. They now have an “outperform” rating on the stock.
• 1/16/2026 – Corteva had its price target raised by Mizuho from $78.00 to $80.00. They now have an “outperform” rating on the stock.
• 1/8/2026 – Corteva had its price target raised by Bank of America Corporation from $80.00 to $82.00. They now have a “buy” rating on the stock.
• 1/3/2026 – Corteva was downgraded by Wall Street Zen from “buy” to “hold”.
• 12/29/2025 – Corteva had its “hold (c-)” rating reaffirmed by Weiss Ratings.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is 45.57%.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.14% of the company’s stock.

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.